Immunomodulator loaded microneedle arrays for targeted intradermal drug delivery to skin tumors
Topical therapy with imiquimod in a cream [5% w/w imiquimod cream (Aldara™)] for the treatment of nodular basal cell carcinoma (BCC) currently results in low cure rates, attributed to low imiquimod permeation. Herein we have developed novel microneedle array patches (MAPs), to maximize imiquimod int...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2025-12-01
|
| シリーズ: | Drug Delivery |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/10717544.2025.2527824 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|